BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Drug Discovery

Ascletis Completes Enrollment for Glioblastoma Treatment Trial

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the completion of enrollment of 120 patients in the Phase III registration clinical trial of ...

September 27, 2023 | News

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

"We're thrilled to strengthen our existing suite of patents," said Peter Choo, Chairman of CytoMed. "Now this novel iPSC-based technology has been gra...

September 26, 2023 | News

MicuRx Receives FDA QIDP and Fast Track Designation for Contezolid & Acefosamil

The QIDP and Fast Track designations were created as part of the Food and Drug Administration Safety and Innovation Act, FDASIA (June 2012), Titl...

September 25, 2023 | News

Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery

Partnerships with BenevolentAI and Exscientia to drive accelerated drug discovery with higher probability of success Access to end-to-end AI platform ca...

September 21, 2023 | News

Everest Medicines Collaborates with Kezar Life Sciences to Develop Zetomipzomib in Greater China and other Asian Markets

"We are glad to form a partnership with Kezar through our cooperation on zetomipzomib, which will add to our existing renal pipeline, and help solidify Eve...

September 21, 2023 | News

Caliway Completes Recruitment for CBL-514 Cellulite Treatment Phase 2 Study

The CBL-0201EFP Phase 2-stage 2 study is an open-label trial that will evaluate the efficacy, safety, and tolerability of CBL-514 in treating subjects with...

September 20, 2023 | News

Kyrgyzstan, Ukraine, and Uzbekistan Revise TB Guidelines for Three-Drug Regimen

Kyrgyzstan, Ukraine, and Uzbekistan — participants in the LIFT-TB project — have updated their National Tuberculosis (TB) Clinic...

September 19, 2023 | News

Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug

Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...

September 18, 2023 | News

Exelixis and Insilico Medicine Ink Global License Deal for ISM3091, a Leading USP1 Inhibitor

— ISM3091 is a highly selective, orally bioavailable small molecule inhibitor of USP1 identified through Insilico Medicine's artificial int...

September 14, 2023 | News

Metabolon Debuts Stress Discovery Panel for Biomarker Detection

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of research, diagnostic, therapeutic development, and preci...

September 13, 2023 | News

Waters Introduces Simplified Solutions for Biologic Drug Analysis

Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and...

September 13, 2023 | News

Singapore's Biosyngen Gets FDA Nod for BRL03 Trials in Advanced Solid Tumors

Notably, BRL03 is also the first TCR-T product developed by Biosyngen to enter clinical trials. This significant achievement is attributed to the...

September 12, 2023 | News

Brii Biosciences Reports Phase 2 Results for BRII-179 in Hepatitis B Combo Treatment

The cohort level unblinded data from the study demonstrated that in the intent to treat analysis at Week 24 (end of treatment or EoT), 26.3% (15 pa...

September 07, 2023 | News

ACM Biolabs Reports Positive Phase I Results for SARS-CoV-2 Booster Vaccine ACM-001

Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform ACM-...

September 06, 2023 | News

Stay Connected